Cytori Therapeutics (CYTX) –
-
Form 8-K CYTORI THERAPEUTICS, For: Jul 29
-
Form 8-K CYTORI THERAPEUTICS, For: Jul 21
-
Form 8-K CYTORI THERAPEUTICS, For: Jul 16
-
Cytori Therapeutics (CYTX) Announces Pending Name/Brand Change to 'Plus Therapeutics Inc.' Under Reserved Ticker 'PSTV'
-
Cytori Will Become Plus Therapeutics, Inc.
-
Cytori to Present Corporate Update & New Strategic Direction
-
Form 8-K CYTORI THERAPEUTICS, For: Jul 11
-
Form 8-K CYTORI THERAPEUTICS, For: Jul 01
-
Form 8-K CYTORI THERAPEUTICS, For: Jul 01
-
Cytori Therapeutics (CYTX) Announces Summary FDA Feedback Regarding its ATI-1123 Product
-
Cytori Reports Summary of FDA Feedback Regarding its ATI-1123 Product
-
Form 8-K CYTORI THERAPEUTICS, For: Jun 27
-
Cytori Announces New Annual Stockholders Meeting Date for July 11
-
Cytori Announces New Annual Stockholders Meeting Date for June 27
-
Form 8-K CYTORI THERAPEUTICS, For: Jun 14
-
Form 8-K CYTORI THERAPEUTICS, For: Jun 13
-
Cytori to Present New Strategic Direction
-
Form 8-K CYTORI THERAPEUTICS, For: May 28
-
Form SD CYTORI THERAPEUTICS,
-
Cytori Announces New Annual Stockholders Meeting Date for June 18
-
Cytori Therapeutics, Inc. (CYTX) PT Lowered to $0.70 at Ascendiant Capital
-
Form 10-Q CYTORI THERAPEUTICS, For: Mar 31
-
Form 8-K CYTORI THERAPEUTICS, For: May 14
-
Cytori Reports Q1 2019 Business and Financial Results
-
Form 8-K CYTORI THERAPEUTICS, For: Apr 24
-
Japan Cell Therapy Transaction Yields $3MM
-
Form 8-K CYTORI THERAPEUTICS, For: Apr 19
-
Form DEF 14A CYTORI THERAPEUTICS, For: May 28
-
Form PRE 14A CYTORI THERAPEUTICS, For: May 28
-
Cytori Therapeutics (CYTX) Tops Q4 EPS by 10c, Revenues Miss
-
Form 8-K CYTORI THERAPEUTICS, For: Apr 01
-
Cytori Reports Fourth Quarter and Full Year 2018 Business and Financial Results
-
Form 8-K CYTORI THERAPEUTICS, For: Mar 30
-
Form 10-K CYTORI THERAPEUTICS, For: Dec 31
-
Cytori to Webcast Fourth Quarter and 2018 Financial Results on April 1
-
Form 8-K CYTORI THERAPEUTICS, For: Mar 15
-
Cytori Files Pre-submission Request for New Drug Application
-
Form 8-K CYTORI THERAPEUTICS, For: Mar 04
-
Form 8-K CYTORI THERAPEUTICS, For: Feb 26
-
Form 8-K CYTORI THERAPEUTICS, For: Feb 13
-
Form S-1 CYTORI THERAPEUTICS,
-
Form 8-K CYTORI THERAPEUTICS, For: Jan 30
-
Cytori Therapeutics (CYTX) announces publication of results of Cytori Cell Therapy in Crohn’s Disease
-
Cytori Cell Therapy™ Clinical Trial Results in Crohn’s Disease
-
Form 8-K CYTORI THERAPEUTICS, For: Dec 31
-
Form 25-NSE CYTORI THERAPEUTICS, Filed by: The Nasdaq Stock Market LLC
-
Cytori Therapeutics (CYTX) Announces Japan Class III Medical Device Approval for Cell Therapy Product
-
Cytori Announces Japan Class III Medical Device Approval for Cell Therapy Product
-
Cytori Therapeutics, Inc. (CYTX) PT Raised to $1.80 at Laidlaw
-
Form 10-Q CYTORI THERAPEUTICS, For: Sep 30
Back to CYTX Stock Lookup